Filter News
Area of Research
- (-) Building Technologies (1)
- (-) Nuclear Science and Technology (24)
- Advanced Manufacturing (6)
- Biology and Environment (4)
- Clean Energy (39)
- Computer Science (2)
- Energy Sciences (1)
- Fuel Cycle Science and Technology (1)
- Fusion and Fission (4)
- Fusion Energy (3)
- Isotopes (3)
- Materials (37)
- Materials for Computing (4)
- National Security (4)
- Neutron Science (6)
- Nuclear Systems Modeling, Simulation and Validation (1)
- Quantum information Science (2)
- Supercomputing (9)
News Topics
- (-) 3-D Printing/Advanced Manufacturing (5)
- (-) Cybersecurity (1)
- (-) Isotopes (5)
- (-) Nuclear Energy (22)
- Advanced Reactors (8)
- Bioenergy (1)
- Biomedical (2)
- Computer Science (2)
- Coronavirus (1)
- Decarbonization (1)
- Environment (1)
- Fusion (6)
- Materials Science (2)
- Molten Salt (4)
- Neutron Science (4)
- Physics (1)
- Space Exploration (2)
- Sustainable Energy (1)
- Transformational Challenge Reactor (3)
Media Contacts
Scientists from Oak Ridge National Laboratory performed a corrosion test in a neutron radiation field to support the continued development of molten salt reactors.
The United Kingdom’s National Nuclear Laboratory and the U.S. Department of Energy’s Oak Ridge National Laboratory have agreed to cooperate on a wide range of nuclear energy research and development efforts that leverage both organizations’ unique expertise and capabilities.
The construction industry may soon benefit from 3D printed molds to make concrete facades, promising lower cost and production time. Researchers at Oak Ridge National Laboratory are evaluating the performance of 3D printed molds used to precast concrete facades in a 42-story buildin...
A tiny vial of gray powder produced at the Department of Energy’s Oak Ridge National Laboratory is the backbone of a new experiment to study the intense magnetic fields created in nuclear collisions.
The Department of Energy’s Oak Ridge National Laboratory is now producing actinium-227 (Ac-227) to meet projected demand for a highly effective cancer drug through a 10-year contract between the U.S. DOE Isotope Program and Bayer.